HIV 1 News and Research

RSS

Uganda government continuing focus on HIV prevention, treatment, amid calls from groups to do more

"Uganda continues to fall short of achieving its goal of ensuring that 80 percent of people living with HIV receive antiretroviral drugs (ARVs) by 2015, according to the Uganda AIDS Commission (UAC)," PlusNews reports.

9 Jan 2013

New compound restores health of mice with MRSA infection

Researchers have discovered a new compound that restores the health of mice infected with methicillin-resistant Staphylococcus aureus (MRSA), an otherwise dangerous bacterial infection. The new compound targets an enzyme not found in human cells but which is essential to bacterial survival.

8 Jan 2013

SNSF-funded professor to receive 2012 National Latsis Prize

On 10 January 2013, Jacques Fellay will receive the National Latsis Prize 2012 at the Rathaus in Berne. The Swiss National Science Foundation (SNSF) is awarding the Prize to the SNSF-funded professor at EPF Lausanne in recognition of his work on the human genome and its defence mechanisms against viral diseases such as AIDS.

8 Jan 2013

Al Jazeera examines HIV in Russia

Al Jazeera continues its coverage of HIV in Russia, where "[t]he latest official figures show that about 200 new cases are being recorded every single day."

8 Jan 2013

Vaccine gives HIV patients a long-term boost

A functional cure for HIV-1 seems feasible after research shows that an immunotherapeutic vaccine demonstrated long-term efficacy at reducing viral load when administered to patients in the early stages of disease.

7 Jan 2013

New research shows rise in number of HIV infections in Russia, Al Jazeera reports

"New research has revealed an alarming spike in the number of HIV infections in Russia, with 200 people being diagnosed with the condition every day," Al Jazeera reports.

7 Jan 2013

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.

7 Jan 2013

Manipulating T cells with iPSC techniques could help develop effective immune therapies

The human body contains immune cells programmed to fight cancer and viral infections, but they often have short lifespans and are not numerous enough to overcome attacks by particularly aggressive malignancies or invasions.

4 Jan 2013

Brazil to require reporting of HIV cases to improve treatment coverage

In "an effort to advance highly lauded efforts to combat AIDS," Brazil will require physicians to report cases of HIV, not just AIDS, to state and federal authorities, the Associated Press/Washington Post reports.

4 Jan 2013

New York Times examines grassroots HIV efforts aimed at gay men in China

The New York Times examines grassroots HIV/AIDS outreach and testing efforts aimed at gay men in China. The newspaper highlights "Lingnan Health Center, an organization run largely by gay volunteers," and recounts the story of Le, "a gay man who would give only his first name."

4 Jan 2013

New technique can precisely add or delete genes in living cells

Researchers at MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes.

4 Jan 2013

CXCR5 molecule effectively polices lung tuberculosis and prevents deadly infection

The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine.

3 Jan 2013

Psychiatric patients at risk of hospitalization due to protected records

Medical centers that elect to keep psychiatric files private and separate from the rest of a person's medical record may be doing their patients a disservice, a Johns Hopkins study concludes.

3 Jan 2013

Wall Street Journal looks at European efforts to fight TB

The Wall Street Journal examines efforts to fight tuberculosis (TB) in Europe, writing, "All along the edges of Western Europe, new and hard-to-defeat strains of tuberculosis are gaining a foothold, often moving beyond traditional victims -- alcoholics, drug users, HIV patients -- and into the wider population."

3 Jan 2013

Salix receives FDA approval for crofelemer to treat HIV-associated diarrhea

On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.

3 Jan 2013

HIV-positive status disclosure rates low in Ethiopia: Study

In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive status disclosure rates among men and women in Africa's second most populous country.

2 Jan 2013

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

2 Jan 2013